VIJAYA DIAGNOSTIC CENTRE
Tee
[wisavn | Ena: intoa vinyaopnostic com
sew shdigmostis com
LABORATORY TEST REPORT.
Regn Date: 06/11/2020 OFT Sample Collstion ; 96/11/2020 09:48
‘Name ‘MR. MOHAMMAD Print Date 07/11/2020 11:41
Regn No + 1020211433 ‘Age’ Sex 1 a0 Years / Feoate
Ref By; Dr. CGHS ON PAYMENT Regn Cente Himayatnagar
Sample Type + Serum Ref to
HIV1 £2 Antibodies
‘TESTNAME RESULT 101 WAL
HIV 1 & 2 Antibodies + Nonteactive (0.09) Nonreactive : <1.0 SiO
Reactive :>/=1.08iCO
‘Matto : Cheroinscen Micrparicle Inmena Aseep (CMI)
for HIV 1 & 2 antibodies.
Reactive Specimen is Positive for HIV - 1 annibodies.
Specimen is Positive for HIV antibodies (HIV-1 and HIV-2; or HIV-2 alone)
‘Confirmation of HIV-2 sero-status at identified referral laboratory through ART centres.
(Gs per the NACO guideline test result is considered positive only when all 3 test are reactive)
Collect fresh sample in 2-4 weeks and repeat the testIf the sample continues to be
{indeterminate send the sample for Western blot or PCR. for confirmation
[All Values are in §/CO units = Ratio of sample Relative Light Units to the Cutoff Relative Light Units
A nonreactive result does not exclude the possibility of HIV infection. Levels of HIV antibodies may be undetectable in the Li
ae
ecu oem
PAE
DR.ANKITA PORWAL
eecteke POUR OUE MEN
* Suggested Clinical Corcelaton, I Necessary Kindly Discuss with signatory NABL AccreitedVIJAYA DIAGNOSTIC CENTRE
[WisAvA | ai: info wayaagmte som
wv. sigaigmosti oan
LABORATORY TEST REPORT
Regn Date 06/11/2000 09:41 Sample Collection ; 06/11/2020 09:45
Name > MR MOHAMMADI Print Date + o7/ny2020 m1:
Regn No: 1020211433 ‘Age/Sex 1 30.Vears / Female
Ref By + Dr. CGHS ON PAYMENT ‘Rega Centre ; Himayatnagar
Sample Type" = Serum Refno :
atitis B. face Anti IBsAy
TEST NAME RESULT H ERY,
TBsAg (Qualitative) + Nonrcastive (0.20) NA
Method Cherminescomt Meropartcle Imouno Assy (CME
Interpretation :
Nomresctive <1.0S/CO Specimen is negative for HBsAg or Hepatitis B virus surface antigens ae a a
undetectable level
Reactive >/= 10S/CO
Results are reported as S/CO units (tatio of Sample Relative Light Units to the Cut off Relative Light Units)
+ This testis for the qualitative detection of Hepatitis B surface Antigen (HBSAg) in human serum,
This testis a highly sensitive screening assays it should not he used as a sole entrion for confirmation of
Hepatitis B infection. Its result should be confirmed by other supplementory tsi.
‘Test results should be interpreted in conjunction with pstient history and other HBV serologic markers (eg, anti-HBs Ab,
anti-HBe Total and anti-HBs IgM, HBeAg & Anti HBe Ab)
~ Individuals, who recently received Hepais B vaccination may have transient positive HBsAg tet results because
of the large dose of HBsAg used inthe vaccine,
+ Anomalous results may be observed in patients who have routine exposure to animals or to animal serum products! who
received preparations of mouse monaelonal antibodies for therapy,
@ sae
DR.ANKITA PORWAL
Conifeate#NEC-857 CONSULTANT MICROBIOLOGIST
* Suggested Clinical Comelation, If Necessary Kinly Discuss with signatory cai
reach neo)VIJAYA DIAGN
DIAGNOSTIC CENTRE
[WIAA] Ena: infovispadagnostic com
own. padi omy
LABORATORY TEST REPORT.
Regn Date 96/11/2020 O91 “Sample Collection : 06/11/2020 09:45
Name MR. MOHAMMADI Print Date (07/11/2020 11:11
Regn No > 1020211433 Age! Sex 3Vears / Female
Ref By = Dr CGHS ON PAYMENT Rega Centre Hiimayatoagar
Sample Type = Serum Ref no
jepatitis. C Virus Antibodies (Anti HCV
STNAME RESULT BIOLOGICAL REFERENCE INTERVAL
‘Anti Hepatitis C Virus Antibodies + Nonreactive 0.95] NA
Method: Chemiinecent Micrpartise Imo Ase (CEA)
Interpretation:
Noa Reactive <1.0S/CO Specimen is negative for HCV antibodies or antibodies are at an undetectable level
Reactive ~=1.0S'CO Specimen for HCV antibodies.
Results are reported as $/CO units (rato of Sample Relative Light Units to the Cutoff Relative Light Units)
This tests for the qualitative deteetion of antibody to Hepatitis C Virus in human serum.
‘This testi only a sereening assay; it should always be used in conjuction with clinical history and exposure risk for
HCY infection.
“This test should not he used asthe sole eriterion for the confirmation of HCV infection and itis recommended
to test farther for HCV RNA detection and quantification by PCR.
* A Nom-teactive screening result docs not exclude the possibilty of exposure to or infection with HCW..
es
DR.ANKITA PORWAL :
Corin 02657 CONSULTANT MICROBIOLOGIST
* Suggested Clinica Correlation, if Necessary Kindly Discuss with signatory
ee ees
NABI Accredited